Table 6.

Mean levels of the hematology profile of participants by group and time period.

	VCO (n = 29)	CONTROL (n = 28)	p-value1
	mean ± SE	mean ± SE
White Blood Cell, uL−1
Baseline	8.1 ± 0.7	7.6 ± 0.5	0.554
Midline	7.9 ± 0.3	8.1 ± 0.3	0.744
Mean Difference (p-value2)	0.2 (0.734)	0.5 (0.367)	0.383
Baseline	8.1 ± 0.7	7.6 ± 0.5	0.554
Endpoint	8.0 ± 0.3	8.0 ± 0.3	0.95
Mean Difference (p-value2)	0.1 (0.834)	0.4 (0.389)	0.464
p-value3	0.839	0.485
Neutrophils, uL−1
Baseline	53.8 ± 2.1	55.3 ± 2.1	0.606
Midline	53.3 ± 1.9	53.8 ± 1.6	0.829
Mean Difference (p-value2)	0.5 (0.803)	1.5 (0.464)	0.725
Baseline	53.8 ± 2.1	55.3 ± 2.1	0.606
Endpoint	51.5 ± 1.7	54.9 ± 1.7	0.171
Mean Difference (p-value2)	2.2 (0.328)	0.4 (0.844)	0.572
p-value3	0.454	0.664
Lymphocytes, uL−1
Baseline	34.2 ± 2.1	32.7 ± 1.9	0.596
Midline	34.3 ± 1.9	33.3 ± 1.4	0.677
Mean Difference (p-value2)	0.1 (0.962)	0.6 (0.723)	0.842
Baseline	34.2 ± 2.1	32.7 ± 1.9	0.596
Endpoint	35.3 ± 1.7	32.6 ± 1.4	0.225
Mean Difference (p-value2)	1.1 (0.588)	1.1 (0.954)	0.663
p-value3	0.724	0.841
Neutrophils/Lymphocytes Ratio
Baseline	1.9 ± 0.2	2.1 ± 0.3	0.577
Midline	1.8 ± 0.2	1.7 ± 0.1	0.731
Mean Difference (p-value2)	0.1 (0.647)	0.4 (0.203)	0.383
Baseline	1.9 ± 0.2	2.1 ± 0.3	0.577
Endpoint	1.6 ± 0.1	1.8 ± 0.1	0.353
Mean Difference (p-value2)	0.3 (0.212)	0.3 (0.398)	0.935
p-value3	0.297	0.313

*significant at p < 0.05.

¹Independent t-test,

²Paired t-test,

³Anova with repeated measure (baseline, midline, and endpoint).